pharmaphorum
AUGUST 16, 2020
There are profound changes taking place in the area of life science research and development,” stated Swittons CEO and Founder Anupam Nandwana. The Swittons software platform is designed to provide life sciences companies with a modern, flexible user interface that not only integrates with other systems, but other IoT devices as well.
pharmaphorum
JANUARY 25, 2022
The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 3, 2023
The field of genomic medicine has reached a true turning point. In June 2022, the European Medicines Agency approved an adeno-associated viral (AAV) vector-based therapy for adults with Hemophilia A, making the treatment available to an estimated 3,200 eligible patients. [1] CEVEC became part of Cytiva in October 2022.
The Pharma Data
MAY 15, 2023
She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. Karen will be Vice Chair of the future Board of Directors of Sandoz as well as the ad interim Chair of its Science, Innovation & Development Committee. Our ambition is to be the world’s leading and most valued generics company.
XTalks
OCTOBER 19, 2023
This could involve tweaking experimental conditions, changing reagents or redesigning the assay. There is also an increasing focus on personalized and precision medicine, where treatments are tailored to individual patients based on genetic or molecular data, which requires assays to detect and quantify these unique markers.
Drug Discovery World
APRIL 3, 2023
As life science operates globally, the vision for the business was always to bring aptamers as an antibody alternative to researchers worldwide. Beyond direct conjugation of therapeutic molecules for delivery, our aptamers can also be conjugated to larger vectors for use in precision medicines.
Drug Discovery World
DECEMBER 28, 2022
Several new products for the life sciences sector have been launched over the last month, from biomarker kits to video-based training platforms. Gyrolab Human Cytokine Kit Reagents are the first in a range of new biomarker kits from Gyros Protein Technologies. . DDW provides an update. .
Expert insights. Personalized for you.
130 
Let's personalize your content